World Journal of Hepatology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Tan YW, Zhou XB, Ye Y, He C, Ge GH. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase. World J Gastroenterol 2017; 23(31): 5746-5754 [PMID: 28883700 DOI: 10.3748/wjg.v23.i31.5746]
URL:	https://www.wjgnet.com/1948-5182/full/v23/i31/5746.htm

(320) (306) (0) (0) (0) (8) (7299) (32)

Number	Citing Articles
1	Wentao Wang, Xueqi Zhao, Guiping Li, Lin Wang, Yizhi Chen, Ke Ma, Guang Chen, Tao Chen, Meifang Han, Qin Ning, Xiping Zhao. Diagnostic thresholds and performance of noninvasive fibrosis scores are limited by age in patients with chronic hepatitis B. Journal of Medical Virology 2019; 91(7) doi: 10.1002/jmv.25435
2	Chi Zhang, Jia-Wen Li, Zhao Wu, Hong Zhao, Gui-Qiang Wang. Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2020.00136
3	Da-Wu Zeng, Zu-Xiong Huang, Meng-Xin Lin, Na-Ling Kang, Xin Lin, Ya-Nan Li, Yue-Yong Zhu, Yu-Rui Liu. A novel HBsAg-based model for predicting significant liver fibrosis among Chinese patients with immune-tolerant phase chronic hepatitis B: a multicenter retrospective study. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211010675
4	Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World Journal of Gastroenterology 2020; 26(27): 3952-3962 doi: 10.3748/wjg.v26.i27.3952 Abstract(1273) \| Core Tip(1130) \| Full Article(HTML)(4762) \| Full Article (PDF)-1018K(563) \| Full Article (Word)-303K(335) \| Audio-1258K(55) \| Peer-Review Report-354K(264) \| Answering Reviewers-297K(278) \| Supplementary Material-81K(243) \| Times Cited (11) \| Total Visits (6956) \| Open
5	Weiwei Geng, Hong Yu, Yuan Li, Li Liu, Yanfang Xiao. Predictive value of serum S100A8/A9 for liver dysfunction in pregnant women with chronic hepatitis B. Virology Journal 2026; 23(1) doi: 10.1186/s12985-026-03190-6
6	Edward John Gane, Michael R. Charlton, Rosmawati Mohamed, Jose Decena Sollano, Kyaw Soe Tun, Thuy Thi Thu Pham, Diana Alcantara Payawal, Rino Alvani Gani, David Handojo Muljono, Subrat Kumar Acharya, Hui Zhuang, Akash Shukla, Kaushal Madan, Neeraj Saraf, Satyendra Tyagi, Karam Romeo Singh, Ian Homer Yee Cua, Ganbolor Jargalsaikhan, Davadoorj Duger, Wattana Sukeepaisarnjaroen, Hery Djagat Purnomo, Irsan Hasan, Laurentius Adrianto Lesmana, Cosmas Rinaldi Adithya Lesmana, Khin Pyone Kyi, Win Naing, Allampura Chandrashekar Ravishankar, Sanjay Hadigal. Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource‐limited settings. Journal of Viral Hepatitis 2020; 27(5) doi: 10.1111/jvh.13244
7	Youwen Tan, Xinyue Zhang. Diagnostic accuracy of FibroScan-AST (FAST) score, non-alcoholic fatty liver fibrosis score (NFS), FibroScan, and liver fibrosis index (FIB-4) for identifying fibrotic non-alcoholic steatohepatitis in patients with chronic hepatitis B with metabolic dysfunction-associated fatty liver disease. Annals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2420858
8	Minmin Zhu, Hui Wang, Tao Lou, Pian Xiong, Jiebing Zhang, Lele Li, Yuchao Sun, Yingping Wu. Current treatment of chronic hepatitis B: Clinical aspects and future directions. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.975584
9	Ping Fan, Lan-Qing Li, En-Qiang Chen. The urgency to expand the antiviral indications of general chronic hepatitis B patients. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1165891
10	J. Qiu, M. Shang, W. Li, H. Zhang, Y. Liao, H. Dong. The expression of sICAM-1 influenced by Clonorchis sinensis co-infection in CHB patients. Journal of Helminthology 2024; 98 doi: 10.1017/S0022149X24000427
11	Yafei Guo, Lingan Wang. Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”. Canadian Journal of Gastroenterology and Hepatology 2019; 2019 doi: 10.1155/2019/4927083
12	Shun Li, Lichen Shi, Xiaoqian Xu, Hao Wang, Hong You, Jidong Jia, Yuanyuan Kong. Systematic review with meta‐analysis: Significant histological changes among treatment‐naïve chronic hepatitis B patients with normal alanine aminotransferase levels by different criteria. Alimentary Pharmacology & Therapeutics 2023; 58(7) doi: 10.1111/apt.17658
13	Qian Luo, Yongmei Li, Lan Luo, Wanglun Diao. Comparisons of the accuracy of radiation diagnostic modalities in brain tumor. Medicine 2018; 97(31) doi: 10.1097/MD.0000000000011256
14	Richard K. Sterling, Keyur Patel, Andres Duarte-Rojo, Sumeet K. Asrani, Mouaz Alsawas, Jonathan A. Dranoff, Maria Isabel Fiel, M. Hassan Murad, Daniel H. Leung, Deborah Levine, Tamar H. Taddei, Bachir Taouli, Don C. Rockey. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology 2025; 81(1) doi: 10.1097/HEP.0000000000000845
15	Lin Wang, Yiqi Liu, Qixin Gu, Chi Zhang, Lei Xu, Lei Wang, Cuiying Chen, Xueen Liu, Hong Zhao, Hui Zhuang. Serum N-Glycan Markers for Diagnosing Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels. Engineering 2023; 26 doi: 10.1016/j.eng.2023.03.008
16	Li Chen, Junjie Shi, Zhonghua Lu, Yun Ye, Xinbei Zhou, Youwen Tan. Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3) doi: 10.1016/j.clinre.2018.10.017
17	Guilherme Moura Cunha, Patrick J Navin, Kathryn J Fowler, Sudhakar K Venkatesh, Richard L Ehman, Claude B Sirlin. Quantitative magnetic resonance imaging for chronic liver disease. The British Journal of Radiology 2021; 94(1121) doi: 10.1259/bjr.20201377
18	Antonio Liguori, Mirko Zoncapè, Giovanni Casazza, Philippa Easterbrook, Emmanuel A Tsochatzis. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2025; 10(4) doi: 10.1016/S2468-1253(24)00437-0
19	Sabina Więcek, Halina Woś, Andrzej Pogorzelski, Bożena Kordys-Darmolinska, Henryk Mazurek, Urszula Grzybowska-Chlebowczyk. Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis. Mediators of Inflammation 2020; 2020 doi: 10.1155/2020/5696185
20	Ruba H. Alhabahbeh, Ala’eddien N. Obeidat, Dunia S. Jaber, Mohammed M. AlKhaldi, Leen K. Ghanem, Ahmad A. Tubasi, Zaina N. Obeidat, Hussam H. Alhawari, Suraiya Saleem. Screening for the Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Among Patients With Prediabetes and Type 2 Diabetes: A Comparison of Three Screening Systems. International Journal of Endocrinology 2025; 2025(1) doi: 10.1155/ije/6676114
21	Zhiqiang Xu, Jinfang Zhao, Jiaye Liu, Yi Dong, Fuchuan Wang, Jianguo Yan, Lili Cao, Pu Wang, Aiqin Li, Jing Li, Shishu Zhu, Yanwei Zhong, Min Zhang, Fu-Sheng Wang. Assessment of liver fibrosis by transient elastography in young children with chronic hepatitis B virus infection. Hepatology International 2021; 15(3) doi: 10.1007/s12072-021-10194-7
22	Yuting Diao, Juan Tang, Xuerong Wang, Wei Deng, Jing Tang, Chunfang You. Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review. Infectious Diseases and Therapy 2023; 12(1) doi: 10.1007/s40121-022-00725-6
23	Yanping Chen, Yanping Li, Na Li, Xiude Fan, Chunyan Li, Pingping Zhang, Qunying Han, Zhengwen Liu. A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels. Disease Markers 2018; 2018 doi: 10.1155/2018/3924732
24	Xin Shu, Haixia Sun, Xiaoan Yang, Yifan Jia, Peiyan Xu, Hong Cao, Ka Zhang. Correlation of effective hepatic blood flow with liver pathology in patients with hepatitis B virus. Liver Research 2021; 5(4) doi: 10.1016/j.livres.2021.11.003
25	Na-Ling Kang, Jie-Min Zhang, Meng-Xin Lin, Xu-Dong Chen, Zu-Xiong Huang, Yue-Yong Zhu, Yu-Rui Liu, Da-Wu Zeng. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World Journal of Gastroenterology 2020; 26(27) doi: 10.3748/wjg.v26.i27.3948 Abstract(0) \| Core Tip(0) \| Full Article(HTML)(0) \| Times Cited (0) \| Total Visits (0) \| Open
26	宇行刘. Research Progress in Histological Features and Related Influencing Factors of Chronic Hepatitis B Patients with Persistent Normal ALT. Advances in Clinical Medicine 2023; 13(05) doi: 10.12677/ACM.2023.1351216
27	Shi-De Lin, Cai-Yun Tian, Han Hu, Jun Long, Hong Zhou. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria. World Journal of Gastroenterology 2019; 25(35): 5323-5333 doi: 10.3748/wjg.v25.i35.5323 Abstract(1636) \| Core Tip(1318) \| Full Article(HTML)(4739) \| Full Article (PDF)-844K(682) \| Full Article (Word)-107K(294) \| Audio-524K(17) \| Peer-Review Report-177K(332) \| Answering Reviewers-94K(346) \| Times Cited (12) \| Total Visits (6960) \| Open
28	Sufang Wei, Qiuli Xie, Guichan Liao, Hongjie Chen, Meixin Hu, Xiaoli Lin, Hong Li, Jie Peng. Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03208-9
29	Yuting Diao, Danqing Hu, Xue Hu, Peng Wang, Xiaojing Wang, Xiaoping Luo, Hongwu Wang, Qin Ning. The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase. Infectious Diseases and Therapy 2022; 11(3) doi: 10.1007/s40121-022-00629-5
30	H. Ben Ayed, M. Koubaa, S. Yaich, K. Rekik, T. Ben Jemaa, I. Maaloul, C. Marrekchi, J. Damak, M. Ben Jemaa. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection. Médecine et Maladies Infectieuses 2019; 49(8) doi: 10.1016/j.medmal.2019.02.004
31	Milan J Sonneveld, Willem P Brouwer, Henry L-Y Chan, Teerha Piratvisuth, Ji-Dong Jia, Stefan Zeuzem, Yun-Fan Liaw, Bettina E Hansen, Hannah Choi, Cynthia Wat, Vedran Pavlovic, Anuj Gaggar, Qing Xie, Maria Buti, Robert J de Knegt, Harry L A Janssen. Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study. The Lancet Gastroenterology & Hepatology 2019; 4(7) doi: 10.1016/S2468-1253(19)30087-1
32	Chi Zhang, Yiqi Liu, Jiawen Li, Hui Liu, Chen Shao, Dan Liu, Min Yu, Hongli Xi, Hong Zhao, Guiqiang Wang. Dose–response relationship between qAnti‐HBc and liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase based on liver biopsy. Journal of Medical Virology 2022; 94(8) doi: 10.1002/jmv.27779